DE60227100D1 - Dimere verbindungen und deren verwendung als antivirale mittel - Google Patents

Dimere verbindungen und deren verwendung als antivirale mittel

Info

Publication number
DE60227100D1
DE60227100D1 DE60227100T DE60227100T DE60227100D1 DE 60227100 D1 DE60227100 D1 DE 60227100D1 DE 60227100 T DE60227100 T DE 60227100T DE 60227100 T DE60227100 T DE 60227100T DE 60227100 D1 DE60227100 D1 DE 60227100D1
Authority
DE
Germany
Prior art keywords
dimere
compounds
antiviral agents
orthomyxovirus
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60227100T
Other languages
German (de)
English (en)
Inventor
Michael D Dowle
Betty Jin
Simon J F Macdonald
Andrew Mcm Mason
Darryl Mcconnell
Van T Nguyen
Stephen E Shanahan
Wen-Yang Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR8798A external-priority patent/AUPR879801A0/en
Priority claimed from AUPS2600A external-priority patent/AUPS260002A0/en
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Application granted granted Critical
Publication of DE60227100D1 publication Critical patent/DE60227100D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60227100T 2001-11-09 2002-11-08 Dimere verbindungen und deren verwendung als antivirale mittel Expired - Lifetime DE60227100D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR8798A AUPR879801A0 (en) 2001-11-09 2001-11-09 Novel chemical compounds and their use
AUPS2600A AUPS260002A0 (en) 2002-05-27 2002-05-27 Novel chemical compounds and their use
PCT/AU2002/001524 WO2003040135A1 (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents

Publications (1)

Publication Number Publication Date
DE60227100D1 true DE60227100D1 (de) 2008-07-24

Family

ID=25646840

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60227100T Expired - Lifetime DE60227100D1 (de) 2001-11-09 2002-11-08 Dimere verbindungen und deren verwendung als antivirale mittel

Country Status (12)

Country Link
US (2) US7157494B2 (enExample)
EP (1) EP1451182B1 (enExample)
JP (2) JP5183853B2 (enExample)
KR (1) KR100942492B1 (enExample)
CN (1) CN1285591C (enExample)
AT (1) ATE398122T1 (enExample)
CA (1) CA2462337C (enExample)
DE (1) DE60227100D1 (enExample)
DK (1) DK1451182T3 (enExample)
ES (1) ES2305300T3 (enExample)
PT (1) PT1451182E (enExample)
WO (1) WO2003040135A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1451182B1 (en) * 2001-11-09 2008-06-11 Biota Scientific Management Pty. Ltd. Dimeric compounds and their use as anti-viral agents
US7560587B2 (en) 2004-12-04 2009-07-14 Xerox Corporation Bis[urea-urethane] compounds
US7576235B2 (en) 2004-12-04 2009-08-18 Xerox Corporation Processes for preparing bis(urea-urethane) compounds
US7144450B2 (en) 2004-12-04 2006-12-05 Xerox Corporation Phase change inks containing trans-1,2-cyclohexane bis(urea-urethane) compounds
US7220300B2 (en) 2004-12-04 2007-05-22 Xerox Corporation Phase change inks containing bis(urea-urethane) compounds
US7314949B2 (en) 2004-12-04 2008-01-01 Xerox Corporation Trans-1,2-cyclohexane bis(urea-urethane) compounds
US7317122B2 (en) 2004-12-04 2008-01-08 Xerox Corporation Curable trans-1,2-cyclohexane bis(urea-urethane) compounds
US7153349B2 (en) 2004-12-04 2006-12-26 Xerox Corporation Phase change inks containing curable trans-1,2-cyclohexane bis(urea-urethane) compounds
CN100471848C (zh) * 2006-06-05 2009-03-25 中国医学科学院医药生物技术研究所 一组长链烷氧烷基取代唾液酸衍生物及其制备方法
CN108003065B (zh) * 2016-10-27 2021-01-08 中国石油化工股份有限公司 一种具有增稠作用的化合物和润滑脂以及它们的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
KR19990087449A (ko) * 1996-03-01 1999-12-27 리차드 웨드레이 인플루엔자 바이러스의 검출방법 및 이에 이용되는 화합물
US6153442A (en) * 1998-05-20 2000-11-28 Dade Behring Inc. Reagents and methods for specific binding assays
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
EP1451182B1 (en) * 2001-11-09 2008-06-11 Biota Scientific Management Pty. Ltd. Dimeric compounds and their use as anti-viral agents
JP2010027130A (ja) 2008-07-17 2010-02-04 Sony Corp 装着機構および出力装置

Also Published As

Publication number Publication date
US20050038108A1 (en) 2005-02-17
CA2462337A1 (en) 2003-05-15
JP2005510519A (ja) 2005-04-21
CN1285591C (zh) 2006-11-22
KR20050044337A (ko) 2005-05-12
DK1451182T3 (da) 2008-10-27
EP1451182B1 (en) 2008-06-11
JP2010270130A (ja) 2010-12-02
EP1451182A4 (en) 2005-02-02
US20070293564A1 (en) 2007-12-20
PT1451182E (pt) 2008-09-17
CA2462337C (en) 2011-09-27
EP1451182A1 (en) 2004-09-01
CN1585765A (zh) 2005-02-23
ATE398122T1 (de) 2008-07-15
KR100942492B1 (ko) 2010-02-12
US7157494B2 (en) 2007-01-02
HK1068346A1 (en) 2005-04-29
JP5183853B2 (ja) 2013-04-17
WO2003040135A1 (en) 2003-05-15
ES2305300T3 (es) 2008-11-01

Similar Documents

Publication Publication Date Title
ATE547416T1 (de) Pyrazolylbenzothiazolderivate und deren verwendung als therapeutische mittel
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
SE0101387D0 (sv) Novel compounds
ATE478664T1 (de) Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren
ECSP003699A (es) Inhibidores de fab i
ATE451349T1 (de) Neue verbindungen als entzündungshemmende, immunmodulierende und antiproliferative mittel
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
DE60010076D1 (de) Chinolinderivate als antibakterielle mittel
ATE373005T1 (de) Thienopyrrole als antivirale mittel
DE60212949D1 (de) Antivirale pyrazolopyridin verbindungen
CY1111843T1 (el) 2-υποκατεστημενα αναλογα βιταμινης d και θεραπευτικες χρησεις αυτων
CY1109245T1 (el) Ενωσεις χρησιμες στην θεραπεια ανθρακα και στην αναστολη θανατηφορου παραγοντα
DE60042401D1 (de) Fab-i inhibitoren
ATE377001T1 (de) Pleuromutilinderivate als antimikrobielle mittel
DE60227100D1 (de) Dimere verbindungen und deren verwendung als antivirale mittel
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
NO20033959L (no) Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon
ATE516284T1 (de) Aromatische verbindungen als entzündungshemmende, immunomodulatorische und antiproliferative mittel
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
ECSP034561A (es) Derivados puente de piperazina
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ATE516031T1 (de) Verbindungen gegen krebs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition